We are international
Donate
TEXT SIZE   


Myeloma Minute
October 8, 2015
10.08.15
October 8, 2015
Share the Minute Facebook Tweet!
Clinical Trials
Donate to the IMF
   

 
This week's question: What is the M Protein?


Multiple Myeloma Bone Study

New Selinexor STORM Clinical Trials: Learn How To Participate

New Ixazomib Clinical Trials: Learn How To Participate

Join the conversation about myeloma on the Smart Patients Message Board

Upcoming Events


Saturday, October 10, 2015
 9th Annual Comedy Celebration

 

Saturday, November 14, 2015
Regional Community Workshop

Washington D.C.

Saturday, November 21, 2015
Regional Community Workshop

Chicago, Illinois


Watch the IMF Mambo for Myeloma & Support This Challenge

    

x

In the News: Myeloma Debates, Drug Costs, Reading that Matters

 

In his blog this week, IMF Chairman Dr. Brian Durie recaps the International Myeloma Workshop (IMW) meeting in Rome, where myeloma experts debated, among other questions, whether we are curing myeloma. He also comments on recent news articles investigating the rise of drug prices, the value of calcium supplements, and if tea is as good for you as coffee. And finally, he connects the dots between antimatter and PET scans. To read Dr. Durie’s blog, click HERE.

 

x

There's Still Time to Be Part of the IMF's 9th Annual Comedy Celebration on Saturday



 

 

 

 

 

 

There are still two days left to purchase tickets to this Saturday’s 9th Annual Comedy Celebration gala, featuring talented comics Jeff Garlin, Tig Notaro, Fred Willard, Heather McDonald, and musical guest Paul Shaffer. Watch the event’s host, Fred Willard, talk about the event on “Good Day LA.” Proceeds from the event benefit the Peter Boyle Research Fund, as well as support the Black Swan Research Initiative®, the IMF's collaborative project aimed at developing the first definitive cure for myeloma. The night kicks off at 6 pm at the Wilshire Ebell Theatre & Club in Los Angeles and you can purchase tickets HERE.

 

x

Clinical Trial to Assess Efficacy of Once-Weekly Dosing for Kyprolis



 

 

 

Onyx/Amgen is conducting the randomized, phase III ARROW clinical trial to potentially provide patients and physicians with a more convenient once-weekly dosing schedule for Kyprolis (carfilzomib).  Currently, Kyprolis is administered by IV infusion twice weekly.  Patients will randomly be assigned to receive Kyprolis either once or twice a week along with weekly dexamethasone.  The ARROW trial is for patients with relapsed and refractory myeloma who have previously been treated with VelcadeR and one of the immunomodulatory drugs: ThalomidR, RevlimidR, or PomalystR.  For more information, read our ARROW Clinical Trial Fact Sheet HERE.

 

 

x

Register Now for the Next Living Well with Myeloma Teleconference on November 19


 

 

 

 

 

 

 

The next teleconference in the Living Well with Myeloma series will be on Thursday, November 19.  IMF Chairman Dr. Brian Durie will present “Myeloma 101:  Updates on Treatment & Pain Management” during this informative teleconference, and will shed light on the most up-to-date therapies for myeloma patientsThe 60-minute teleconference begins at 4 pm PT/7 pm ET and is not to be missed! To register, please click HERE.

 

x

 

 
 

 

 

 

 

 

 


Join Our Mailing List

 
12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF InfoLine: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe
www.myeloma.org

.


 related articles